Japan, July 1 -- FATE THERAPEUTICS INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES.' Other related details are as follows:
Application Number: JP,2023-172588
Category (FI): A61K31/4709,C12N5/0783,C12N5/02,C12N5/10,A61K35/17,A61K35/14,A61K35/28,A61K35/51,A61K35/26,A61K35/545,A61K35/15,A61K35/12,A61K45/00,A61K45/08,A61K38/00,A61K38/19,A61K38/18,A61K39/395@D,A61K31/7105,A61K31/713,A61P37/02,A61P43/00,105,A61K31/506,A61K31/5025,A61K31/519,A61K31/5377,A61K31/7004,A61P37/06,A61P35/02,A61P35/00,A61P31/18,A61P31/14,A61P31/20,A61K40/11,A61K40/15,A61K40/31,A61K40/32,A61K40/50
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 4, 2023
P...